Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 8.77%150.63M | 5.49%85.11M | 11.04%138.48M | 2.49%80.69M | -5.96%124.71M | -17.67%78.73M | -30.53%132.61M | -16.62%95.62M | -5.79%190.88M | 6.06%114.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 82.70%-1.64M | 51.64%-1.12M | 2.12%-9.47M | -83.80%-2.31M | -30.02%-9.68M | 67.04%-1.26M | -58.83%-7.44M | -49.63%-3.82M | 32.79%-4.69M | 30.51%-2.55M |
| Attributable subsidiary (profit) loss | 58.85%-1.13M | 165.98%2.24M | 8.45%-2.75M | -113.63%-3.4M | 32.86%-3.01M | 47.18%-1.59M | -11.40%-4.48M | -2.13%-3.01M | -43.19%-4.02M | -37.13%-2.95M |
| Impairment and provisions: | -27.52%29.78M | 25.70%29.48M | -29.95%41.09M | -10.41%23.45M | 8.43%58.66M | 20.61%26.18M | 67.46%54.1M | 12.69%21.7M | 41.47%32.31M | -48.95%19.26M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-875K | ---876K | --875K | ---- |
| -Impairment of trade receivables (reversal) | -25.43%15.38M | 36.08%28.05M | -21.25%20.63M | 21.30%20.61M | 35.59%26.2M | 4.40%16.99M | 1.45%19.32M | --16.28M | 12.10%19.04M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --14.99M | ---- | ---- | ---- |
| -Other impairments and provisions | -29.63%14.4M | -49.75%1.43M | -36.98%20.46M | -69.10%2.84M | 57.07%32.47M | 45.71%9.18M | 66.86%20.67M | -67.27%6.3M | 111.83%12.39M | 200.33%19.26M |
| Revaluation surplus: | -40.66%5.29M | -40.42%1.95M | 42.03%8.91M | 171.42%3.28M | 39.32%6.27M | -79.88%1.21M | 358.23%4.5M | 2,877.31%6M | -299.77%-1.74M | 89.87%-216K |
| -Fair value of investment properties (increase) | -11.12%5.29M | -29.68%1.95M | 282.13%5.95M | 380.28%2.78M | 3,075.51%1.56M | 227.59%578K | 102.68%49K | 90.47%-453K | -162.21%-1.83M | -1,030.14%-4.75M |
| -Other fair value changes | ---- | ---- | -37.20%2.96M | -20.51%500K | 5.91%4.72M | -90.25%629K | 5,329.27%4.45M | 42.21%6.45M | -68.46%82K | 271.66%4.54M |
| Asset sale loss (gain): | -569.96%-1.63M | 24.65%450K | -107.17%-243K | -50.62%361K | 141.29%3.39M | 108.62%731K | -179.51%-8.21M | -28,366.67%-8.48M | 811.23%10.32M | 102.03%30K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | 98.27%-145K | -185.22%-8.37M | ---8.37M | 746.12%9.82M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -457.98%-1.82M | -48.20%187K | 0.31%-326K | -14.66%361K | -299.39%-327K | 481.08%423K | 121.84%164K | -470.00%-111K | -1,188.41%-751K | -26.83%30K |
| -Loss (gain) from selling other assets | 130.12%191K | --263K | -97.77%83K | ---- | --3.72M | --453K | ---- | ---- | --1.25M | ---- |
| Depreciation and amortization: | -18.33%38.07M | -14.88%20.15M | 11.26%46.61M | -3.68%23.67M | -0.50%41.9M | 29.46%24.58M | -13.64%42.11M | -38.50%18.99M | -18.62%48.76M | 13.26%30.87M |
| -Depreciation | -16.91%27.19M | -16.11%14.74M | 17.93%32.72M | -3.15%17.57M | 0.87%27.75M | 56.35%18.14M | 7.89%27.51M | -16.34%11.61M | 11.18%25.5M | 50.80%13.87M |
| -Amortization of intangible assets | -9.28%8.62M | -7.68%4.47M | -7.18%9.51M | -8.55%4.85M | -14.07%10.24M | -6.49%5.3M | -8.17%11.92M | -20.05%5.67M | -6.86%12.98M | 6.72%7.09M |
| Financial expense | -13.56%2.05M | -0.69%865K | -12.14%2.37M | -8.41%871K | 9.82%2.69M | -34.50%951K | -51.55%2.45M | -71.30%1.45M | -65.22%5.06M | -42.81%5.06M |
| Exchange Loss (gain) | 54.64%733K | -143.82%-482K | 124.97%474K | 308.73%1.1M | -361.07%-1.9M | -518.25%-527K | 382.88%727K | 110.90%126K | 87.36%-257K | 15.62%-1.16M |
| Operating profit before the change of operating capital | -1.47%222.14M | 8.57%138.65M | 1.09%225.47M | -1.00%127.7M | 3.08%223.04M | 0.33%128.99M | -21.78%216.38M | -21.13%128.57M | -3.35%276.63M | -4.75%163.02M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 269.07%4.77M | 122.70%7.21M | -323.91%-2.82M | 264.53%3.24M | 96.89%-665K | 90.39%-1.97M | -37.84%-21.37M | 64.44%-20.47M | -95.34%-15.5M | -3,271.14%-57.58M |
| Accounts receivable (increase)decrease | -632.33%-63.03M | -64.65%-168.15M | 117.32%11.84M | 2.76%-102.13M | 47.46%-68.37M | 38.35%-105.03M | -23.39%-130.12M | 23.11%-170.36M | -435.61%-105.45M | -9.40%-221.57M |
| Accounts payable increase (decrease) | 102.14%3.77M | 94.90%-2.54M | -545.64%-176.39M | -24.03%-49.82M | -52.25%39.58M | -201.96%-40.17M | 250.83%82.9M | -72.66%39.4M | 172.38%23.63M | 834.59%144.07M |
| prepayments (increase)decrease | -85.95%7.88M | -99.01%130K | 256.69%56.09M | 449.55%13.16M | -567.69%-35.8M | -141.24%-3.76M | 95.19%-5.36M | 117.22%9.13M | -264.04%-111.48M | -209.83%-52.99M |
| Cash from business operations | 53.73%175.53M | -214.67%-24.71M | -27.64%114.19M | 64.21%-7.85M | 10.79%157.79M | -59.64%-21.94M | 110.00%142.43M | 45.15%-13.74M | -76.53%67.82M | -197.66%-25.05M |
| Other taxs | 37.25%-34.77M | 18.12%-23.26M | -64.39%-55.41M | -26.89%-28.41M | 42.77%-33.71M | 8.38%-22.39M | -73.28%-58.9M | -194.12%-24.44M | 52.63%-33.99M | 81.17%-8.31M |
| Net cash from operations | 139.50%140.76M | -32.28%-47.97M | -52.63%58.77M | 18.20%-36.26M | 48.55%124.09M | -16.10%-44.33M | 146.89%83.53M | -14.45%-38.18M | -84.43%33.83M | -80.65%-33.36M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -82.70%1.64M | -51.41%1.12M | -2.12%9.47M | 84.24%2.3M | 30.02%9.68M | -26.64%1.25M | 60.30%7.44M | 5.71%1.7M | -17.49%4.64M | 61.04%1.61M |
| Dividend received - investment | ---- | ---- | 23.79%2.97M | ---- | -14.92%2.4M | ---- | 10.58%2.82M | 10.63%2.82M | 16.96%2.55M | --2.55M |
| Sale of fixed assets | 228.43%5.15M | 290.00%468K | -61.05%1.57M | --120K | 40.59%4.03M | ---- | 138.75%2.87M | -9.85%2.24M | 49.25%1.2M | 364.18%2.49M |
| Purchase of fixed assets | 7.62%-22.08M | 7.28%-7.4M | 9.04%-23.9M | 47.05%-7.98M | -31.57%-26.27M | -37.73%-15.08M | 59.06%-19.97M | 19.78%-10.95M | -115.06%-48.77M | -123.50%-13.65M |
| Purchase of intangible assets | ---- | ---- | 92.76%-69K | ---- | 66.85%-953K | 79.92%-48K | -12.88%-2.88M | -4,680.00%-239K | -613.45%-2.55M | 98.67%-5K |
| Sale of subsidiaries | ---- | ---- | --2M | ---- | ---- | 92.31%2.38M | 149.70%1.24M | --1.24M | 123.96%495K | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 101.23%444K | 101.71%444K |
| Recovery of cash from investments | 567.71%1.28M | --1.15M | -98.82%192K | ---- | 6,434.80%16.34M | 1,460.00%3.9M | -66.67%250K | --250K | --750K | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | 94.89%-3.08M | ---- | -5,886.78%-60.23M | ---19.83M | 32.12%-1.01M | ---- |
| Other items in the investment business | ---- | ---- | ---- | 22.22%11K | ---2.45M | -81.25%9K | ---- | 100.07%48K | ---- | -166.44%-67.71M |
| Net cash from investment operations | -80.37%-14M | 15.98%-4.66M | -2,396.14%-7.76M | 26.89%-5.55M | 99.55%-311K | 66.58%-7.59M | -62.06%-68.46M | 69.42%-22.71M | 47.67%-42.24M | -7.68%-74.27M |
| Net cash before financing | 148.50%126.76M | -25.87%-52.63M | -58.79%51.01M | 19.47%-41.81M | 721.27%123.77M | 14.74%-51.92M | 279.18%15.07M | 43.42%-60.9M | -106.16%-8.41M | -23.10%-107.63M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -19.98%40M | -19.84%40M | -61.25%49.99M | 1.86%49.9M | 122.80%128.99M | -8.40%48.99M | -15.54%57.9M | 0.11%53.48M | -43.81%68.55M | -41.93%53.43M |
| Refund | 13.46%-45.92M | 6.27%-45.92M | 58.87%-53.06M | 0.00%-48.99M | -192.83%-128.99M | -140.88%-48.99M | 50.35%-44.05M | 65.13%-20.34M | 51.17%-88.72M | -40.36%-58.32M |
| Interest paid - financing | 13.56%-2.05M | 0.69%-865K | 12.14%-2.37M | 8.41%-871K | -9.82%-2.69M | 21.34%-951K | 31.27%-2.45M | -492.65%-1.21M | -21.56%-3.57M | 85.89%-204K |
| Dividends paid - financing | -23.86%-31.75M | -108.14%-4.4M | 24.29%-25.64M | 10.61%-2.11M | -68.14%-33.86M | -157.07%-2.37M | 20.79%-20.14M | 95.92%-920K | 25.48%-25.43M | -9.73%-22.53M |
| Absorb investment income | 3,611.54%1.93M | -101.38%-50K | --52K | 374.97%3.62M | ---- | -88.06%763K | -14.74%6.89M | 26.28%6.39M | 2,275.00%8.08M | --5.06M |
| Net cash from financing operations | -7.84%-39.86M | -2,321.06%-12.13M | 7.92%-36.96M | 114.79%546K | -743.83%-40.14M | -110.29%-3.69M | 90.70%-4.76M | 194.51%35.86M | 49.98%-51.16M | -173.04%-37.94M |
| Effect of rate | -54.64%-733K | 143.82%482K | -124.97%-474K | -308.73%-1.1M | 361.07%1.9M | 518.25%527K | -382.88%-727K | -110.90%-126K | -92.66%257K | 120.61%1.16M |
| Net Cash | 518.63%86.9M | -56.92%-64.76M | -83.20%14.05M | 25.79%-41.27M | 710.79%83.63M | -122.12%-55.61M | 117.32%10.32M | 82.80%-25.04M | -273.81%-59.57M | -310.24%-145.58M |
| Begining period cash | 2.55%545.16M | 2.55%545.16M | 19.18%531.58M | 19.18%531.58M | 2.20%446.05M | 2.20%446.05M | -11.96%436.46M | -11.96%436.46M | 8.25%495.77M | 8.25%495.77M |
| Cash at the end | 15.81%631.32M | -1.70%480.88M | 2.55%545.16M | 25.13%489.22M | 19.18%531.58M | -4.94%390.97M | 2.20%446.05M | 17.06%411.3M | -11.96%436.46M | -16.95%351.35M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.